<?xml version="1.0" encoding="UTF-8"?>
<!--NOS V1.0 (10-04-2026)-->
<xbrli:xbrl xmlns:in-capmkt="https://www.sebi.gov.in/xbrl/2024-05-31/in-capmkt" xmlns:in-capmkt-ent="https://www.sebi.gov.in/xbrl/Notice_Of_Shareholders_Meeting/2024-05-31/in-capmkt/in-capmkt-ent" xmlns:in-capmkt-roles="https://www.sebi.gov.in/xbrl/Notice_Of_Shareholders_Meeting/2024-05-31/in-capmkt-roles" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink"><link:schemaRef xlink:type="simple" xlink:href="in-capmkt-ent-2024-05-31.xsd"/><xbrli:context id="MainI"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-08-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="D_DetailofRPT1"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain1</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_DetailofRPT2"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain2</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_DetailofRPT3"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain3</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_DetailofRPT4"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain4</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_DetailofRPT5"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain5</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_DetailofRPT6"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain6</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_DetailofRPT7"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain7</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_DetailofResolution1"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ResolutionOrAgendaAxis"><in-capmkt:ResolutionOrAgendaDomain>ResolutionOrAgendaDomain1</in-capmkt:ResolutionOrAgendaDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_DetailofResolution1"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-08-25</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ResolutionOrAgendaAxis"><in-capmkt:ResolutionOrAgendaDomain>ResolutionOrAgendaDomain1</in-capmkt:ResolutionOrAgendaDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_DetailofResolution2"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ResolutionOrAgendaAxis"><in-capmkt:ResolutionOrAgendaDomain>ResolutionOrAgendaDomain2</in-capmkt:ResolutionOrAgendaDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_DetailofResolution2"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-08-25</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ResolutionOrAgendaAxis"><in-capmkt:ResolutionOrAgendaDomain>ResolutionOrAgendaDomain2</in-capmkt:ResolutionOrAgendaDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_DetailofResolution3"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ResolutionOrAgendaAxis"><in-capmkt:ResolutionOrAgendaDomain>ResolutionOrAgendaDomain3</in-capmkt:ResolutionOrAgendaDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_DetailofResolution3"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-08-25</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ResolutionOrAgendaAxis"><in-capmkt:ResolutionOrAgendaDomain>ResolutionOrAgendaDomain3</in-capmkt:ResolutionOrAgendaDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_DetailofResolution4"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ResolutionOrAgendaAxis"><in-capmkt:ResolutionOrAgendaDomain>ResolutionOrAgendaDomain4</in-capmkt:ResolutionOrAgendaDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_DetailofResolution4"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-08-25</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ResolutionOrAgendaAxis"><in-capmkt:ResolutionOrAgendaDomain>ResolutionOrAgendaDomain4</in-capmkt:ResolutionOrAgendaDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_DetailofResolution5"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-25</xbrli:startDate><xbrli:endDate>2026-08-25</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ResolutionOrAgendaAxis"><in-capmkt:ResolutionOrAgendaDomain>ResolutionOrAgendaDomain5</in-capmkt:ResolutionOrAgendaDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_DetailofResolution5"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/NSESymbol">SOLARA</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-08-25</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ResolutionOrAgendaAxis"><in-capmkt:ResolutionOrAgendaDomain>ResolutionOrAgendaDomain5</in-capmkt:ResolutionOrAgendaDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:unit id="INR"><xbrli:measure>iso4217:INR</xbrli:measure></xbrli:unit><xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><in-capmkt:NSESymbol contextRef="MainI">SOLARA</in-capmkt:NSESymbol><in-capmkt:NameOfTheCompany contextRef="MainI">Solara Active Pharma Sciences Limited</in-capmkt:NameOfTheCompany><in-capmkt:TypeOfAnnouncement contextRef="MainI">New</in-capmkt:TypeOfAnnouncement><in-capmkt:DateOfOccurrenceOfEvent contextRef="MainI">2026-09-18</in-capmkt:DateOfOccurrenceOfEvent><in-capmkt:TimeOfOccurrenceOfEvent contextRef="MainI">10:30:00</in-capmkt:TimeOfOccurrenceOfEvent><in-capmkt:DateOfReport contextRef="MainI">2026-08-25</in-capmkt:DateOfReport><in-capmkt:EventForNoticeOfShareholdersMeeting contextRef="MainI">Annual General Meeting</in-capmkt:EventForNoticeOfShareholdersMeeting><in-capmkt:ModeOfShareholdersMeeting contextRef="MainI">Video Conference (VC) or Other Audio-Visual Means (OAVM)</in-capmkt:ModeOfShareholdersMeeting><in-capmkt:NumberOfShareholdersMeeting contextRef="MainI">1</in-capmkt:NumberOfShareholdersMeeting><in-capmkt:DayOfShareholdersMeeting contextRef="MainI">Friday</in-capmkt:DayOfShareholdersMeeting><in-capmkt:DateOfShareholdersMeeting contextRef="MainI">2026-09-18</in-capmkt:DateOfShareholdersMeeting><in-capmkt:ShareholdersMeetingCommencementTime contextRef="MainI">10:30:00</in-capmkt:ShareholdersMeetingCommencementTime><in-capmkt:PlaceOfShareholdersMeeting contextRef="MainI">Through VC</in-capmkt:PlaceOfShareholdersMeeting><in-capmkt:NumberOfAgendaOrBusinessToBeTransacted contextRef="MainI" unitRef="pure" decimals="0">5</in-capmkt:NumberOfAgendaOrBusinessToBeTransacted><in-capmkt:RemarksForWebsiteDisseminationForShareholdersMeeting contextRef="MainI">Solara Partly Paid up shares: &lt;BR&gt; 
Paid up at Rs. 7/- and ISIN - IN9624Z01022 &lt;BR&gt; 
Symbol - SOLARAPP1  &lt;BR&gt; 
Scrip Code - 890202  &lt;BR&gt; 
</in-capmkt:RemarksForWebsiteDisseminationForShareholdersMeeting><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_DetailofRPT1">Solara Active Pharma Sciences Limited</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_DetailofRPT1">Strides Pharma Science Limited</in-capmkt:NameOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_DetailofRPT1">Mr. Arun Kumar is common Promoter and Non-Executive Director in Solara Active Pharma Sciences Limited and Strides Pharma Science Limited ("Strides")</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_DetailofRPT1">Sale of goods or services</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_DetailofRPT1" unitRef="INR" decimals="0">4500000000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:DateOfStartOfTenure contextRef="D_DetailofRPT1">2026-09-18</in-capmkt:DateOfStartOfTenure><in-capmkt:DateOfEndOfTenure contextRef="D_DetailofRPT1">2027-09-18</in-capmkt:DateOfEndOfTenure><in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction contextRef="D_DetailofRPT1">A Related Party Transaction between the Companies as stated hereunder is proposed to be entered from the date of this Annual General Meeting (“AGM”) up to the date of next AGM, subject to the approval of shareholders at the Ninth Annual General Meeting of the Company. The Tenure (end date) has been stated as 18-09-2026 for validation purpose only.</in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_DetailofRPT2">Solara Active Pharma Sciences Limited</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_DetailofRPT2">Strides Pharma Science Limited</in-capmkt:NameOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_DetailofRPT2">Mr. Arun Kumar is common Promoter and Non-Executive Director in Solara Active Pharma Sciences Limited and Strides Pharma Science Limited ("Strides")</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_DetailofRPT2">Sale of goods or services</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_DetailofRPT2" unitRef="INR" decimals="0">100000000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:DateOfStartOfTenure contextRef="D_DetailofRPT2">2026-09-18</in-capmkt:DateOfStartOfTenure><in-capmkt:DateOfEndOfTenure contextRef="D_DetailofRPT2">2027-09-18</in-capmkt:DateOfEndOfTenure><in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction contextRef="D_DetailofRPT2">A Related Party Transaction between the Companies as stated hereunder is proposed to be entered from the date of this Annual General Meeting (“AGM”) up to the date of next AGM, subject to the approval of shareholders at the Ninth Annual General Meeting of the Company. The Tenure (end date) has been stated as 18-09-2026 for validation purpose only.</in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_DetailofRPT3">Solara Active Pharma Sciences Limited</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_DetailofRPT3">Strides Pharma Science Limited</in-capmkt:NameOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_DetailofRPT3">Mr. Arun Kumar is common Promoter and Non-Executive Director in Solara Active Pharma Sciences Limited and Strides Pharma Science Limited ("Strides")</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_DetailofRPT3">Purchase of goods or services</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_DetailofRPT3" unitRef="INR" decimals="0">9500000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:DateOfStartOfTenure contextRef="D_DetailofRPT3">2026-09-18</in-capmkt:DateOfStartOfTenure><in-capmkt:DateOfEndOfTenure contextRef="D_DetailofRPT3">2027-09-18</in-capmkt:DateOfEndOfTenure><in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction contextRef="D_DetailofRPT3">A Related Party Transaction between the Companies as stated hereunder is proposed to be entered from the date of this Annual General Meeting (“AGM”) up to the date of next AGM, subject to the approval of shareholders at the Ninth Annual General Meeting of the Company. The Tenure (end date) has been stated as 18-09-2026 for validation purpose only.</in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_DetailofRPT4">Solara Active Pharma Sciences Limited</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_DetailofRPT4">Strides Pharma Science Limited</in-capmkt:NameOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_DetailofRPT4">Mr. Arun Kumar is common Promoter and Non-Executive Director in Solara Active Pharma Sciences Limited and Strides Pharma Science Limited ("Strides")</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_DetailofRPT4">Purchase of goods or services</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_DetailofRPT4" unitRef="INR" decimals="0">20000000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:DateOfStartOfTenure contextRef="D_DetailofRPT4">2026-09-18</in-capmkt:DateOfStartOfTenure><in-capmkt:DateOfEndOfTenure contextRef="D_DetailofRPT4">2027-09-18</in-capmkt:DateOfEndOfTenure><in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction contextRef="D_DetailofRPT4">A Related Party Transaction between the Companies as stated hereunder is proposed to be entered from the date of this Annual General Meeting (“AGM”) up to the date of next AGM, subject to the approval of shareholders at the Ninth Annual General Meeting of the Company. The Tenure (end date) has been stated as 18-09-2026 for validation purpose only.</in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_DetailofRPT5">Solara Active Pharma Sciences Limited</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_DetailofRPT5">Strides Pharma Science Limited</in-capmkt:NameOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_DetailofRPT5">Mr. Arun Kumar is common Promoter and Non-Executive Director in Solara Active Pharma Sciences Limited and Strides Pharma Science Limited ("Strides")</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_DetailofRPT5">Any other transaction</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:DetailsOfOtherRelatedPartyTransaction contextRef="D_DetailofRPT5">Reimbursement of expenses to Strides</in-capmkt:DetailsOfOtherRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_DetailofRPT5" unitRef="INR" decimals="0">20000000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:DateOfStartOfTenure contextRef="D_DetailofRPT5">2026-09-18</in-capmkt:DateOfStartOfTenure><in-capmkt:DateOfEndOfTenure contextRef="D_DetailofRPT5">2027-09-18</in-capmkt:DateOfEndOfTenure><in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction contextRef="D_DetailofRPT5">A Related Party Transaction between the Companies as stated hereunder is proposed to be entered from the date of this Annual General Meeting (“AGM”) up to the date of next AGM, subject to the approval of shareholders at the Ninth Annual General Meeting of the Company. The Tenure (end date) has been stated as 18-09-2026 for validation purpose only.</in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_DetailofRPT6">Solara Active Pharma Sciences Limited</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_DetailofRPT6">Strides Pharma Science Limited</in-capmkt:NameOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_DetailofRPT6">Mr. Arun Kumar is common Promoter and Non-Executive Director in Solara Active Pharma Sciences Limited and Strides Pharma Science Limited ("Strides")</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_DetailofRPT6">Any other transaction</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:DetailsOfOtherRelatedPartyTransaction contextRef="D_DetailofRPT6">Reimbursement of expenses from Strides</in-capmkt:DetailsOfOtherRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_DetailofRPT6" unitRef="INR" decimals="0">150000000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:DateOfStartOfTenure contextRef="D_DetailofRPT6">2026-09-18</in-capmkt:DateOfStartOfTenure><in-capmkt:DateOfEndOfTenure contextRef="D_DetailofRPT6">2027-09-18</in-capmkt:DateOfEndOfTenure><in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction contextRef="D_DetailofRPT6">A Related Party Transaction between the Companies as stated hereunder is proposed to be entered from the date of this Annual General Meeting (“AGM”) up to the date of next AGM, subject to the approval of shareholders at the Ninth Annual General Meeting of the Company. The Tenure (end date) has been stated as 18-09-2026 for validation purpose only.</in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_DetailofRPT7">Solara Active Pharma Sciences Limited</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_DetailofRPT7">Strides Pharma Science Limited</in-capmkt:NameOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_DetailofRPT7">Mr. Arun Kumar is common Promoter and Non-Executive Director in Solara Active Pharma Sciences Limited and Strides Pharma Science Limited ("Strides")</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_DetailofRPT7">Any other transaction</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:DetailsOfOtherRelatedPartyTransaction contextRef="D_DetailofRPT7">Lease rent payable to Strides</in-capmkt:DetailsOfOtherRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_DetailofRPT7" unitRef="INR" decimals="0">500000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:DateOfStartOfTenure contextRef="D_DetailofRPT7">2026-09-18</in-capmkt:DateOfStartOfTenure><in-capmkt:DateOfEndOfTenure contextRef="D_DetailofRPT7">2027-09-18</in-capmkt:DateOfEndOfTenure><in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction contextRef="D_DetailofRPT7">A Related Party Transaction between the Companies as stated hereunder is proposed to be entered from the date of this Annual General Meeting (“AGM”) up to the date of next AGM, subject to the approval of shareholders at the Ninth Annual General Meeting of the Company. The Tenure (end date) has been stated as 18-09-2026 for validation purpose only.</in-capmkt:RemarksForTenureOfTheRelatedPartyTransaction><in-capmkt:TypeOfResolution contextRef="I_DetailofResolution1">Ordinary Resolution</in-capmkt:TypeOfResolution><in-capmkt:CategoryOfResolution contextRef="I_DetailofResolution1">Adoption of Financial Statements</in-capmkt:CategoryOfResolution><in-capmkt:BriefDetailsOfResolution contextRef="D_DetailofResolution1">To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon</in-capmkt:BriefDetailsOfResolution><in-capmkt:TypeOfResolution contextRef="I_DetailofResolution2">Ordinary Resolution</in-capmkt:TypeOfResolution><in-capmkt:CategoryOfResolution contextRef="I_DetailofResolution2">Adoption of Financial Statements</in-capmkt:CategoryOfResolution><in-capmkt:BriefDetailsOfResolution contextRef="D_DetailofResolution2">To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Report of the Auditors thereon</in-capmkt:BriefDetailsOfResolution><in-capmkt:TypeOfResolution contextRef="I_DetailofResolution3">Ordinary Resolution</in-capmkt:TypeOfResolution><in-capmkt:CategoryOfResolution contextRef="I_DetailofResolution3">Appointment/Re-appointment/Removal/Ratification/Retirement/Remuneration</in-capmkt:CategoryOfResolution><in-capmkt:SubCategoryOfResolution contextRef="I_DetailofResolution3">Retirement by rotation</in-capmkt:SubCategoryOfResolution><in-capmkt:BriefDetailsOfResolution contextRef="D_DetailofResolution3">To appoint Mr. Arun Kumar Pillai (DIN: 00084845), who retires by rotation and being eligible offers himself for re-appointment as a Non - Executive Director</in-capmkt:BriefDetailsOfResolution><in-capmkt:DesignationOfDesignatedPerson contextRef="I_DetailofResolution3">Non-Executive - Non-Independent Director</in-capmkt:DesignationOfDesignatedPerson><in-capmkt:NameOfDesignatedPerson contextRef="D_DetailofResolution3">Arun Kumar Pillai</in-capmkt:NameOfDesignatedPerson><in-capmkt:DirectorIdentificationNumberOfDirector contextRef="D_DetailofResolution3">00084845</in-capmkt:DirectorIdentificationNumberOfDirector><in-capmkt:DateOfStartOfTenure contextRef="D_DetailofResolution3">2021-08-04</in-capmkt:DateOfStartOfTenure><in-capmkt:DateOfEndOfTenure contextRef="D_DetailofResolution3">2021-08-04</in-capmkt:DateOfEndOfTenure><in-capmkt:TypeOfResolution contextRef="I_DetailofResolution4">Ordinary Resolution</in-capmkt:TypeOfResolution><in-capmkt:CategoryOfResolution contextRef="I_DetailofResolution4">Others</in-capmkt:CategoryOfResolution><in-capmkt:SubCategoryOfResolution contextRef="I_DetailofResolution4">Others</in-capmkt:SubCategoryOfResolution><in-capmkt:DetailsOfOtherSubCategoryOfResolution contextRef="D_DetailofResolution4">To ratify the remuneration payable to Cost Auditors for the financial year ending March 31, 2027</in-capmkt:DetailsOfOtherSubCategoryOfResolution><in-capmkt:BriefDetailsOfResolution contextRef="D_DetailofResolution4">To ratify the remuneration payable to Cost Auditors for the financial year ending March 31, 2027</in-capmkt:BriefDetailsOfResolution><in-capmkt:TypeOfResolution contextRef="I_DetailofResolution5">Ordinary Resolution</in-capmkt:TypeOfResolution><in-capmkt:CategoryOfResolution contextRef="I_DetailofResolution5">Related Party Transaction</in-capmkt:CategoryOfResolution><in-capmkt:BriefDetailsOfResolution contextRef="D_DetailofResolution5">To approve Material Related Party Transactions/ Contracts/ Arrangements with Strides Pharma Science Limited up to 480 crores</in-capmkt:BriefDetailsOfResolution></xbrli:xbrl>
